Vanguard Group Portfolio holdings
Vanguard Group is an investment manager owned by the funds it manages, and so by its own customers. John Bogle founded it in 1975 and is credited with creating the first index fund available to individual investors. After Wellington Management fired Bogle in 1974, he started a new fund division there and named it Vanguard after HMS Vanguard, Horatio Nelson's flagship. Bogle set up its first index fund in 1976, the fund that became the Vanguard 500 Index Fund, and the firm added a bond index fund in 1986. It began offering ETFs in 2001 as exchange-traded shares of its index funds, and it also serves employers' retirement plans and independent financial advisers. Salim Ramji, who came from BlackRock, was named chief executive in 2024 as the first outsider to lead the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.03B |
| 2 |
Microsoft
MSFT
|
+$8B |
| 3 |
Apple
AAPL
|
+$7.21B |
| 4 |
TotalEnergies
TTE
|
+$5.18B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.85B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$2.74B |
| 2 |
DuPont de Nemours
DD
|
+$2.65B |
| 3 |
Mr. Cooper
COOP
|
+$1.41B |
| 4 |
Interpublic Group of Companies
IPG
|
+$1.24B |
| 5 |
Amazon
AMZN
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 9.9% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
BARK
BARK
$82.6M
| $4.13M | ﹤0.01% |
342,652
+1,953
| +0.6% | +$29K |
2021 Q3
17 quarters
|
|
3327
DELISTED
Karyopharm Therapeutics
KPTI
| $4.12M | ﹤0.01% |
559,619
+151,397
| +37% | +$926K |
2013 Q4
48 quarters
|
|
3328
Wrap Technologies
WRAP
$91.8M
| $4.11M | ﹤0.01% |
1,726,740
+65,832
| +4% | +$159K |
2019 Q1
27 quarters
|
|
3329
Prelude Therapeutics
PRLD
$275M
| $4.1M | ﹤0.01% |
1,413,986
+421,132
| +42% | +$711K |
2020 Q3
21 quarters
|
|
3330
Atara Biotherapeutics
ATRA
$78.5M
| $4.09M | ﹤0.01% |
225,940
+22,502
| +11% | +$336K |
2014 Q4
44 quarters
|
|
3331
Aemetis
AMTX
$86.6M
| $4.08M | ﹤0.01% |
2,935,000
+455,837
| +18% | +$917K |
2014 Q3
45 quarters
|
|
3332
Rent the Runway
RENT
$76.7M
| $4.07M | ﹤0.01% |
515,090
+415,258
| +416% | +$2.24M |
2021 Q4
16 quarters
|
|
3333
XMAX Inc
XMAX
$383M
| $4.07M | ﹤0.01% |
677,899
+554,286
| +448% | +$3.12M |
2025 Q3
1 quarter
|
|
3334
Quantum Corp
QMCO
$607M
| $4.03M | ﹤0.01% |
625,538
+321,941
| +106% | +$2.89M |
2020 Q2
22 quarters
|
|
3335
Fortress Biotech
FBIO
$62.7M
| $4.03M | ﹤0.01% |
1,100,570
+150,243
| +16% | +$428K |
2013 Q2
50 quarters
|
|
3336
GrowGeneration
GRWG
$73.3M
| $4.02M | ﹤0.01% |
2,679,874
-31,805
| -1% | -$52.2K |
2020 Q2
22 quarters
|
|
3337
Seer Inc
SEER
$87.6M
| $4M | ﹤0.01% |
2,187,413
-33,991
| -2% | -$69.3K |
2020 Q4
20 quarters
|
|
3338
ADC Therapeutics
ADCT
$188M
| $3.99M | ﹤0.01% |
1,129,587
+535,633
| +90% | +$2.17M |
2024 Q2
6 quarters
|
|
3339
Cherry Hill Mortgage Investment Corp
CHMI
$82M
| $3.98M | ﹤0.01% |
1,561,850
+37,596
| +2% | +$91.6K |
2013 Q4
48 quarters
|
|
3340
Sidus Space
SIDU
$95.2M
| $3.98M | ﹤0.01% |
1,267,451
+704,823
| +125% | +$813K |
2024 Q1
7 quarters
|
|
3341
QuickLogic
QUIK
$176M
| $3.97M | ﹤0.01% |
660,791
+4,914
| +0.7% | +$31.8K |
2013 Q2
50 quarters
|
|
3342
Fifth District Bancorp
FDSB
$92.1M
| $3.96M | ﹤0.01% |
264,034
+410
| +0.2% | +$5.63K |
2024 Q4
4 quarters
|
|
3343
iShares Russell 1000 ETF
IWB
$47.8B
| $3.96M | ﹤0.01% |
10,592
-642
| -6% | -$238K |
2023 Q1
11 quarters
|
|
3344
Elicio Therapeutics
ELTX
$42.5M
| $3.96M | ﹤0.01% |
496,901
+23,042
| +5% | +$209K |
2021 Q1
19 quarters
|
|
3345
Insight Molecular Diagnostics
IMDX
$70M
| $3.95M | ﹤0.01% |
526,675
+39,937
| +8% | +$225K |
2016 Q1
39 quarters
|
|
3346
Tilray
TLRY
$359M
| $3.95M | ﹤0.01% |
436,921
+32,598
| +8% | +$398K |
2019 Q2
26 quarters
|
|
3347
MeiraGTx Holdings
MGTX
$882M
| $3.93M | ﹤0.01% |
494,753
+30,818
| +7% | +$256K |
2018 Q4
28 quarters
|
|
3348
Korro Bio
KRRO
$187M
| $3.92M | ﹤0.01% |
489,639
+93,980
| +24% | +$2.2M |
2019 Q4
24 quarters
|
|
3349
Cartesian Therapeutics
RNAC
$194M
| $3.9M | ﹤0.01% |
541,228
+20,506
| +4% | +$166K |
2016 Q2
38 quarters
|
|
3350
aTyr Pharma
ATYR
$15.6M
| $3.89M | ﹤0.01% |
124,047
-16,726
| -12% | -$549K |
2015 Q2
42 quarters
|
|
Similar funds
Vanguard Group's Q4 2025 Portfolio in Review
As of Q4 2025, Vanguard Group held 4,426 positions worth $6.9T, up 3.3% from $6.68T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.1%. Vanguard Group opened 82 new positions and exited 98, leaving the 4,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2025 buy was TotalEnergies: 81,863,403 shares worth $5.34B.
- Vanguard Group added most to NVIDIA in Q4 2025, an estimated $8.03B increase.
- Vanguard Group's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $2.65B.
- Vanguard Group fully exited Kellanova in Q4 2025, selling an estimated $2.74B.
- Vanguard Group's ten largest holdings make up 31% of its $6.9T portfolio in Q4 2025.
- Vanguard Group opened 82 new positions and closed 98 in Q4 2025.
- Vanguard Group's portfolio value rose 3.3% quarter-over-quarter to $6.9T.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.